miRNA Expression Profiling Regulates Epithelial Mesenchymal Transition in 125I Seed Irradiation of Gastric Carcinoma Cell
Abstract Backgroud The aim of this study is to examine miRNA profiling and miR-1285-3p participates in 125I seed irradiation of gastric carcinoma cell via the regulation of epithelial mesenchymal transition (EMT). Methods An in vitro I-125 seed irradiation model was established, followed by the small RNA-Sequencing to investigate the full spectrum of miRNAs that are response to I-125 seed implantation. Validation was performed with quantitative real time PCR (qRT-PCR). qRT-PCR was also employed to measure miR-1285-3p and EMT-related mRNAs expression. Western blotting assay was performed to test the expression of EMT-related proteins. Luciferase reporter assay was conducted to confirm the direct targeting of SMAD2/3 and SMAD4 by miR-1285-3p.Results A total of 1034 miRNAs were initially detected. Of these, 11 miRNAs were significantly differentially expressed between I-125 seed irradiation and control groups. Six miRNAs (hsa-miR-127-3p, hsa-miR-1285-3p, hsa-miR-296-5p, hsa-miR-421, hsa-miR-495-3p, and hsa-miR-548am-3p) were up regulation and five miRNAs (hsa-miR-17-5p, hsa-miR-193b-5p, hsa-miR-23b-5p, hsa-miR-483-5p, hsa-miR-92a-1-5p) were down regulation between I-125 seed irradiation treatment and control groups. EMT is involved in gastric cancer cells treatment with I-125 seed implantation, and downregulation of miR-1285-3p can repress EMT through its targeting of SMAD pathway, which make miR-1285-3p a novel target of I-125 therapeutic intervention for human gastric cancer.Conclusions This study revealed that miR-1285-3p inhibited EMT by targeting SMAD pathway in 125I seed irradiation of gastric carcinoma.